BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28536426)

  • 1. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.
    Zhang G; Liu Z; Ding H; Miao H; Garcia JM; Li YP
    Sci Rep; 2017 May; 7(1):2273. PubMed ID: 28536426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
    Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
    Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
    Zhang G; Jin B; Li YP
    EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways.
    Doyle A; Zhang G; Abdel Fattah EA; Eissa NT; Li YP
    FASEB J; 2011 Jan; 25(1):99-110. PubMed ID: 20826541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia.
    Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A
    Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.
    Sin TK; Zhu JZ; Zhang G; Li YP
    Cancer Res; 2019 Apr; 79(7):1331-1342. PubMed ID: 30705122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2.
    Zhang G; Lin RK; Kwon YT; Li YP
    FASEB J; 2013 Jul; 27(7):2893-901. PubMed ID: 23568773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 mediates the development of fatigue in the murine Lewis Lung Carcinoma model independently of activation of macrophages and microglia.
    Vichaya EG; Ford BG; Quave CB; Rishi MR; Grossberg AJ; Dantzer R
    Psychoneuroendocrinology; 2020 Dec; 122():104874. PubMed ID: 32979744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
    Puppa MJ; Gao S; Narsale AA; Carson JA
    FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.
    Gao S; Carson JA
    Am J Physiol Cell Physiol; 2016 Jan; 310(1):C66-79. PubMed ID: 26491045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome.
    Henriques F; Lopes MA; Franco FO; Knobl P; Santos KB; Bueno LL; Correa VA; Bedard AH; Guilherme A; Birbrair A; Peres SB; Farmer SR; Batista ML
    Sci Rep; 2018 Dec; 8(1):18024. PubMed ID: 30575787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90.
    Zhang G; Liu Z; Ding H; Zhou Y; Doan HA; Sin KWT; Zhu ZJ; Flores R; Wen Y; Gong X; Liu Q; Li YP
    Nat Commun; 2017 Sep; 8(1):589. PubMed ID: 28928431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling.
    Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X
    Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90.
    Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.
    Yoshimura T; Saitoh K; Sun L; Wang Y; Taniyama S; Yamaguchi K; Uchida T; Ohkubo T; Higashitani A; Nikawa T; Tachibana K; Hirasaka K
    Biochem Biophys Res Commun; 2018 Dec; 506(4):773-779. PubMed ID: 30389140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes.
    Guigni BA; van der Velden J; Kinsey CM; Carson JA; Toth MJ
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E22-E32. PubMed ID: 31689144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
    Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.